Major Study Finds No Strong Link Between Antidepressants in Pregnancy and Child Neurodevelopmental Disorders

A large-scale study has found no clear link between most antidepressants taken during pregnancy and neurodevelopmental disorders in children. The research, covering over half a million pregnancies, challenges earlier concerns about increased risks of autism and ADHD. Scientists now suggest that family history and genetic factors play a far bigger role than medication alone.

The systematic review and meta-analysis examined data from 37 studies involving more than 500,000 pregnancies exposed to antidepressants. Initially, small increases in autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) risks appeared. But after adjusting for maternal mental health conditions and other influencing factors, these elevated risks largely disappeared.

Selective serotonin reuptake inhibitors (SSRIs), the most commonly prescribed antidepressants, showed no increased risk for children when mothers had diagnosed mental health disorders. However, two older tricyclic antidepressants—amitriptyline and nortriptyline—remained weakly associated with higher ASD and ADHD risks. Researchers believe this may reflect the severity of parental mental illness rather than the drugs themselves. The study also noted similar risk patterns in children whose fathers took antidepressants during the pregnancy or whose mothers used them before but not during pregnancy. This finding reinforces the idea that shared genetic and environmental factors within families heavily influence neurodevelopment. Unlike previous research, this analysis carefully controlled for parental health, revealing how earlier studies may have overestimated medication-related risks. No dose-response relationship was found, meaning higher antidepressant doses did not correspond to greater neurodevelopmental risks in children. The findings emphasise the need for nuanced discussions between doctors and pregnant women about mental health treatment.

The research concludes that most antidepressants do not directly raise the risk of autism or ADHD in children. Instead, genetic and familial factors appear far more significant. Clinicians are encouraged to consider these complex influences when advising pregnant women on managing depression, ensuring decisions are based on a full understanding of both risks and benefits.